世界的に広がる統合的がん治療 ― UCアーバイン主導の国際研究(UC Irvine-led study finds global embrace of integrative cancer care)

ad

2025-11-24 カリフォルニア大学アーバイン校(UCI)

カリフォルニア大学アーバイン校(UCI)が主導した国際研究により、補完代替医療(CAM)と標準がん医療を組み合わせた“統合的がんケア” が世界的に急速に受け入れられていることが明らかになった。研究チームは70超の国・地域から集めた臨床データ、患者調査、医療提供体制の情報を総合分析し、特にアジア・欧州では、鍼灸、ヨガ、栄養療法、マインドフルネス、植物由来製剤などを疼痛管理・不安軽減・治療副作用緩和のために正式に医療システムへ組み込む例が増えていることを確認した。統合医療を受けた患者は、症状負担の軽減、生活の質(QOL)の改善、治療継続率の向上が報告される一方、エビデンスの質や標準化不足、医療アクセス格差が依然課題となっている。研究者らは、統合的がんケアは“患者中心の全人的医療”として重要性が増しており、今後は科学的根拠の強化と国際的ガイドライン整備が必要だと結論づけている。

<関連情報>

症状管理のための統合腫瘍学的モダリティの評価:MASCC/SIOグローバル調査 Evaluation of integrative oncology modalities for symptom management: a MASCC/SIO global survey

Alexandre Chan,Reem Nasr,Daniela Arcos,Dalia Kagramanov,Chioma Asuzu,Ting Bao,Yin Ting Cheung,Jung Hye Kwon,Judith Lacey,Richard T. Lee,Maryam Lustberg,Beatrice M. Ohaeri,Santosh Rao,Enrique Soto-Perez-de-Celis,Claudia M. Witt & Ana Maria Lopez
BMC Complementary Medicine and Therapies  Published:03 November 2025
DOI:https://doi.org/10.1186/s12906-025-05157-6

世界的に広がる統合的がん治療 ― UCアーバイン主導の国際研究(UC Irvine-led study finds global embrace of integrative cancer care)

Abstract

Background

With growing evidence pointing towards the potential of integrative oncology modalities (IOM) in addressing cancer and cancer-treatment related symptoms, research on IOM utilization and implementation is warranted. This study examines global stakeholder perspectives on integrative oncology (IO) utilization for supportive cancer care.

Methods

Members of the Multinational Association of Supportive Care in Cancer (MASCC) and the Society for Integrative Oncology (SIO) completed a survey on the utilization of IOM for supportive cancer care. Descriptive statistics were used to assess demographic data, IOM usage patterns, IOM education, and financial considerations for utilizing IOM.

Results

Among 344 participants representing eight geographical regions, 70% reported having utilized or recommended IOM and 79% perceived IOM to be underutilized in cancer supportive care. Acupuncture (48%), exercise classes (39%), nutrition (38%), breathing/yoga (38%) and personalized exercise (38%) were among the most utilized IOM across regions. Relatedly, the symptoms for which IOM were most recommended for persons with a diagnosis of cancer in active treatment [AT] or completed treatment [CT] respectively were emotional (AT 23%; CT 26%), pain (AT 22%; CT 20%), gastrointestinal (AT 21%; CT 12%) and fatigue (AT 15%; CT 16%). The perceived availability of integrative medicine training was highest in North America (69%). Across regions, self-pay (20%-67%), private insurance (0%-26%) and government insurance (7%-40%) were the most common forms of payment for IOM. The IOM most recommended in high-income countries (acupuncture, exercise, massage, individual exercise) varied from the IOM most recommended in low-middle income countries (nutrition counseling, exercise classes, breathing, acupuncture).

Conclusion

This study provides valuable insights into global utilization patterns of IOM in supportive cancer care, highlighting that while most respondents have utilized IOM, there is a perceived underutilization overall. Our results show significant regional differences in the availability of integrative oncology education and hint to financial barriers impacting IOM use. Further research is necessary to explore these aspects and inform strategies for supporting IOM implementation efforts.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました